Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.
Kanbe M, Sunaga N, Hara K, Sawada H, Wakamatsu I, Hara K, Muto S, Sawada Y, Masubuchi H, Sato M, Miura Y, Tsurumaki H, Yatomi M, Sakurai R, Koga Y, Ohtaki Y, Nagashima T, Okano N, Kubo N, Maeno T, Hisada T.
Kanbe M, et al. Among authors: nagashima t.
Thorac Cancer. 2022 Nov;13(22):3225-3228. doi: 10.1111/1759-7714.14678. Epub 2022 Oct 4.
Thorac Cancer. 2022.
PMID: 36193787
Free PMC article.